ArriVent BioPharma Inc.. (AVBP) NASDAQ
$19.94 0.44 (2.26%)
Market Cap: $653.13M
As of 05/16/24 03:59 PM EDT. Market closed.
ArriVent BioPharma Inc.. (AVBP)
NASDAQ
$19.94
0.44 (2.26%)
Market Cap: $653.13M
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
PRICE CHART FOR ARRIVENT BIOPHARMA INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$19.39
Previous Close
$19.50
Days Range
$18.74 - $19.55
52 week range
$14.35 - $25.95
Volume
57,002
Avg. Volume (30 days)
92,006
Market Cap
$653.13M
Dividend Yield
-
P/E
-
Shares Outstanding
33,493,750
Open
$19.39
Previous Close
$19.50
Days Range
$18.74 - $19.55
52 week range
$14.35 - $25.95
Volume
57,002
Avg. Volume (30 days)
92,006
Market Cap
$653.13M
Dividend Yield
-
P/E
-
Shares Outstanding
33,493,750
FINANCIAL STATEMENTS FOR ARRIVENT BIOPHARMA INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ARRIVENT BIOPHARMA INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10% Owner | Jan 30, 2024 | Buy | $18.00 | 555,555 | 9,999,990 | 4,484,672 | Feb 01, 2024, 04:47 PM |
| ORBIMED ADVISORS LLC | Director | Jan 30, 2024 | Buy | $18.00 | 444,444 | 7,999,992 | 1,513,664 | Jan 31, 2024, 04:12 PM |
| GORDON CARL L | Director | Jan 30, 2024 | Buy | $18.00 | 444,444 | 7,999,992 | 1,513,664 | Jan 31, 2024, 04:11 PM |
| HEALY JAMES | Director | Jan 30, 2024 | Buy | $18.00 | 444,444 | 7,999,992 | 1,696,752 | Jan 31, 2024, 04:10 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10% Owner | 01/30/2024 | 9,999,990 |
| ORBIMED ADVISORS LLC | Director | 01/30/2024 | 7,999,992 |
| GORDON CARL L | Director | 01/30/2024 | 7,999,992 |
| HEALY JAMES | Director | 01/30/2024 | 7,999,992 |
FUNDS WITH A POSITION IN ARRIVENT BIOPHARMA INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 3,929,117 | 1.52% | New | Other |
| ORBIMED ADVISORS LLC | 3,027,328 | 0.99% | New | Other |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,563,709 | 1.04% | New | Growth At A Reasonable Price |
| BLACKROCK INC. | 654,804 | 0.00027% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 225,049 | 0.00037% | New | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 151,768 | 0.01% | New | Event Driven, Value |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,181 | 0.03% | New | Value |
| BLACKSTONE INC. | 25,000 | 0.0018% | New | Other |
BUYBACK ANNOUNCEMENT(S) FOR ARRIVENT BIOPHARMA INC.
LOADING...